13 March 2024
Emcure Pharmaceuticals has announced its foray into the over-the-counter (OTC) market with the launch of its flagship product, Galact. According to a press release, Galact, a lactation supplement designed to enhance breast milk production, has been prescribed by healthcare professionals for over two decades and will now be available as an OTC offering.
Stay Connected, Stay Informed –
Don’t miss out on exclusive updates, market trends, and real-time investment opportunities. Be the first to know about the latest unlisted stocks, IPO announcements, and curated Fact Sheets, delivered straight to your WhatsApp.